SCHEMBL5215970

SCHEMBL5215970

CCOC(=O)c1c(S(=O)(=O)N2CCOCC2)c2ccccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.48
LMNA P02545 3/20 0.48
MAPT P10636 3/20 0.48
GAA P10253 2/20 0.48
HTT P42858 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
USP2 O75604 2/20 0.43
POLB P06746 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5214826 0.90 CCR2 (0.48) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5214833 0.90 CCR2 (0.48) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5219974 0.87 CCR2 (0.63) CCR2LMNAMAPTHTTALDH1A1
SCHEMBL5219665 0.86 CCR2 (0.56) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5216150 0.83 CCR2 (0.55) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5215724 0.81 CCR2 (0.50) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5213680 0.80 CCR2 (0.65) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5216641 0.79 MEN1 (0.63) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5214927 0.79 CCR2 (0.59) CCR2SMN1; SMN2LMNAMAPTGAA
SCHEMBL5216535 0.79 CCR2 (0.59) CCR2SMN1; SMN2LMNAMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed